MOROCTOCOG ALFA — all Canadian products
10 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is MOROCTOCOG ALFA, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02309491 | XYNTHA | PFIZER CANADA ULC | Powder For Solution; Kit | Intravenous | MOROCTOCOG ALFA 500 UNIT | Marketed | |
| 02309483 | XYNTHA | PFIZER CANADA ULC | Powder For Solution; Kit | Intravenous | MOROCTOCOG ALFA 250 UNIT | Marketed | |
| 02374099 | XYNTHA SOLOFUSE | PFIZER CANADA ULC | Powder For Solution | Intravenous | MOROCTOCOG ALFA 3000 UNIT | Marketed | |
| 02374064 | XYNTHA SOLOFUSE | PFIZER CANADA ULC | Powder For Solution | Intravenous | MOROCTOCOG ALFA 500 UNIT | Marketed | |
| 02374072 | XYNTHA SOLOFUSE | PFIZER CANADA ULC | Powder For Solution | Intravenous | MOROCTOCOG ALFA 1000 UNIT | Marketed | |
| 02374080 | XYNTHA SOLOFUSE | PFIZER CANADA ULC | Powder For Solution | Intravenous | MOROCTOCOG ALFA 2000 UNIT | Marketed | |
| 02374056 | XYNTHA SOLOFUSE | PFIZER CANADA ULC | Powder For Solution | Intravenous | MOROCTOCOG ALFA 250 UNIT | Approved | |
| 02245951 | REFACTO | WYETH CANADA | Powder For Solution | Intravenous | MOROCTOCOG ALFA 1000 UNIT | Cancelled Post Market | |
| 02309505 | XYNTHA | PFIZER CANADA ULC | Powder For Solution; Kit | Intravenous | MOROCTOCOG ALFA 1000 UNIT | Dormant | |
| 02309513 | XYNTHA | PFIZER CANADA ULC | Powder For Solution; Kit | Intravenous | MOROCTOCOG ALFA 2000 UNIT | Dormant |
Browse other molecules: